ArticleCJC open2025
Persistent Mental Health-Related Disparities in Stroke Prevention for Atrial Fibrillation in the Era of Direct Oral Anticoagulants.
Article in CJC open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mental health condition (MHC)-related oral anticoagulant prescribing disparities in atrial fibrillation have been reported. We evaluated oral anticoagulant prescribing for atrial fibrillation with the use of 2019 data and compared results with a previous analysis of warfarin prescribing that used 2004 data to evaluate impact of direct oral anticoagulant availability on oral anticoagulant prescribing. Methods: This cross-sectional analysis compared oral anticoagulant prescribing in atrial fibrillation for patients with and without MHCs by means of Poisson regression and compared with a previous analysis. Results: Of 305,937 patients with atrial fibrillation and CHADS Conclusions: Significant disparities in oral anticoagulant prescribing for persons with atrial fibrillation and MHCs persist. Further research should evaluate the drivers of disparate prescribing and implement processes to ensure equitable prescribing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.